Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. | MicrobiomeTrials← Back to trialsNCT06772064
Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-04-15Est. Completion: 2025-12-01
Enrollment target: 115 participants Locations- Qilu Hospital of Shandong University, Jinan, Shandong, China
Other microbiome trials you might be interested in
Extensive Stage Lung Small Cell Carcinoma
This phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizum…
Birmingham, United StatesEst. completion Apr 30, 2027
Malignant Glioma
This phase I/II trial tests the safety, side effects, and best dose of selinexor given in combination with standard radi…
Birmingham, United StatesEst. completion Jun 30, 2027
Phase 3
Recruiting
Low Grade AstrocytomaLow Grade GliomaMetastatic Low Grade AstrocytomaMetastatic Low Grade GliomaWHO Grade 1 GliomaWHO Grade 2 Glioma
This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincr…
Birmingham, United StatesEst. completion Dec 31, 2030